Aclaris Therapeutics, Inc. (0H8T.L)
USD 3.14
(6.34%)
USD 3.14
(6.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 31.24 Million | 29.75 Million | 6.76 Million | 6.48 Million | 4.22 Million | 6.15 Million |
| Cost of Revenue | 116.46 Million | 11.96 Million | 4.71 Million | 5.13 Million | 4.05 Million | 4.32 Million |
| Gross Profit | -85.21 Million | 17.79 Million | 2.04 Million | 1.34 Million | 172 Thousand | 1.82 Million |
| Operating Expenses | 12.14 Million | 102.94 Million | 67.43 Million | 49.86 Million | 91 Million | 85.33 Million |
| Selling, General and Administrative Expenses | 32.41 Million | 25.13 Million | 23.61 Million | 20.53 Million | 27.22 Million | 25.76 Million |
| Research and Development Expenses | 105.01 Million | 77.81 Million | 43.81 Million | 29.33 Million | 63.78 Million | 59.56 Million |
| Other Expenses | -125.28 Million | - | - | - | - | - |
| Cost and Expenses | 128.6 Million | 114.9 Million | 72.14 Million | 55 Million | 95.05 Million | 89.65 Million |
| Operating Income | -97.35 Million | -85.15 Million | -65.38 Million | -48.51 Million | -90.83 Million | -83.5 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -367 Thousand | - | - | -182 Thousand | 47.81 Million | 1.16 Million |
| Earnings before Tax | -88.84 Million | -86.9 Million | -90.86 Million | -51.33 Million | -113.54 Million | -82.1 Million |
| Net Income | -88.48 Million | -86.9 Million | -90.86 Million | -51.01 Million | -161.35 Million | -132.73 Million |
| Earnings Per Share Basic | -1.27 | -1.33 | -1.60 | -1.20 | -3.90 | -4.03 |
| Earnings Per Share Diluted | -1.27 | -1.33 | -1.60 | -1.20 | -3.90 | -4.03 |
| Weighted Average Shares Outstanding | 69.67 Million | 65.21 Million | 56.73 Million | 42.53 Million | 41.32 Million | 32.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.8 Million | 65.21 Million | 56.73 Million | 42.53 Million | 41.32 Million | 32.9 Million |
| Gross Margin | -2.73 | 0.60 | 0.30 | 0.21 | 0.04 | 0.30 |
| EBIT Margin | -2.82 | -2.84 | -9.53 | -7.28 | -21.11 | -13.36 |
| Profit Margin | -2.83 | -2.92 | -13.44 | -7.87 | -38.17 | -21.58 |
| EBITDA | -87.98 Million | -89.05 Million | -89.94 Million | -50.01 Million | -111.95 Million | -80.78 Million |
| Earnings Before Tax Margin | -3.12 | -2.86 | -9.67 | -7.49 | -21.49 | -13.58 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.76 Million | 2.39 Million | 17.57 Million | 31.24 Million | 9.28 Million | 1.86 Million |
| Cost of Revenue | 10.66 Million | 1.84 Million | 6.42 Million | 18.08 Million | 848 Thousand | 1.04 Million |
| Gross Profit | -7.9 Million | 558 Thousand | 11.14 Million | 13.16 Million | 8.43 Million | 827 Thousand |
| Operating Expenses | 4.95 Million | 14.18 Million | 31.76 Million | 127.69 Million | 30.96 Million | 33.59 Million |
| Selling, General and Administrative Expenses | 4.75 Million | 4.34 Million | 5.11 Million | - | 7.09 Million | 8.31 Million |
| Research and Development Expenses | 8.75 Million | 9.84 Million | 26.64 Million | - | 23.87 Million | 25.27 Million |
| Other Expenses | -8.55 Million | - | - | - | - | - |
| Cost and Expenses | 15.62 Million | 16.02 Million | 38.18 Million | 145.77 Million | 31.81 Million | 34.63 Million |
| Operating Income | -12.85 Million | -13.63 Million | -20.61 Million | -114.52 Million | -22.53 Million | -32.76 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 200 Thousand | - | -367 Thousand | -367 Thousand | - | 1.00 |
| Earnings before Tax | -10.98 Million | -16.94 Million | -1.85 Million | -88.84 Million | -29.26 Million | -29.56 Million |
| Net Income | -10.98 Million | -16.94 Million | -1.49 Million | -88.48 Million | -29.26 Million | -29.56 Million |
| Earnings Per Share Basic | -0.15 | -0.24 | -0.02 | - | -0.41 | -0.42 |
| Earnings Per Share Diluted | -0.15 | -0.24 | -0.02 | - | -0.41 | -0.42 |
| Weighted Average Shares Outstanding | 71.29 Million | 71.07 Million | 70.86 Million | 69.8 Million | 70.8 Million | 70.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 71.29 Million | 71.07 Million | 70.86 Million | 69.8 Million | 70.8 Million | 70.63 Million |
| Gross Margin | -2.86 | 0.23 | 0.63 | 0.42 | 0.91 | 0.44 |
| EBIT Margin | -4.56 | -5.58 | -1.16 | - | -2.40 | -17.41 |
| Profit Margin | -3.97 | -7.06 | -0.08 | -2.83 | -3.15 | -15.82 |
| EBITDA | -12.61 Million | -13.38 Million | -20.39 Million | - | -22.31 Million | -32.54 Million |
| Earnings Before Tax Margin | -4.65 | -5.68 | -1.17 | -3.67 | -2.43 | -17.53 |
STEM
WLY
078935
5714
000028
FG